Eisai Inc.

This study is testing a new drug called E7386 in combination with other cancer medications for people with advanced solid tumors, including endometrial, liver, and colorectal cancers. The main goals are to find the safest and most effective dose and to see how well the drug combi…

This study is testing whether adding a new investigational drug called E2814 to an existing Alzheimer's medication (lecanemab) is safe and can better slow the disease. It will involve about 105 people with early-stage Alzheimer's disease. Researchers will measure changes in a spe…

This large, late-stage study is testing whether the drug lecanemab can slow the progression of early Alzheimer's disease. Nearly 2,000 participants with mild memory problems will receive either the drug or a placebo for 18 months, followed by an optional long-term extension phase…

This early-stage study is testing the safety of combining two drugs, H3B-6545 and palbociclib, for women with advanced or metastatic breast cancer that is hormone-sensitive and HER2-negative. The main goal is to find the highest dose patients can tolerate without severe side effe…

This large, late-stage trial tested whether two new drug combinations work better than the current standard treatment for advanced kidney cancer. It enrolled over 1000 patients who had not yet received treatment for their advanced disease. The goal was to see if the combinations …

This is the first study in people testing a new oral drug called E7386 for advanced cancers that have stopped responding to standard treatments. Researchers will give the drug to about 60 patients with specific tumor types, including liver cancer, to find the safest and most effe…

This program provided continued access to perampanel medication for people with epilepsy who had previously participated in related studies. It allowed patients to keep receiving their seizure medication until it became commercially available in their country. The program was des…

This study is testing an experimental drug called BB-1701 for people with advanced breast cancer that has spread or cannot be removed by surgery. The trial aims to find the safest and most effective dose and see how well the drug shrinks tumors in patients who have already receiv…

This large study is testing whether the drug lecanemab can prevent or delay Alzheimer's disease in people who have early signs of the disease in their brains but do not yet have memory problems or other symptoms. It involves 1,400 participants aged 55-80 who have intermediate or …